By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View Privacy Policy for more information.

We bring the platform, you bring the assay

Our open platform and collaborative process give developers a breakthrough method to bring point-of-care assays to the market-faster.

Fluxergy testing card

Your assays,
our OEM platform

Streamlined development

Our open platform eliminates testing, hardware and regulatory hurdles that slow down the current assay development process. This allows development partners to focus on their strengths—developing new assays that will diversify their portfolio and bring them to the market faster.

Built on collaboration

Our partnerships are built on an equitable sharing of profits and a clear separation of IP. Our development partners own all rights and regulatory filing for an assay, which gives you control over branding for all test kits, including cartridges. We retain ownership of the analyzer and FluxergyWorks.

Fluxergy analyzer with card

Reimagining the OEM workflow

See the difference Fluxergy can make to improve your OEM workflow.

1

Develop Assay on 96 well plate

2

Develop hardware to replicate assay process

Fluxergy Logo

3

Test assay in R&D hardware configuration

4

Adjust hardware to make assay work

Fluxergy Logo

5

Complete R&D with working R&D assay and hardware configuration

6

Evaluate hardware and assay changes to allow for cost down/ supply chain

Fluxergy Logo

7

Test assay and hardware changes

Fluxergy Logo

8

Evaluate hardware and assay changes for manufacturability (automation, IPQC's, etc.)

Fluxergy Logo

9

Test assay and hardware changes

Fluxergy Logo

10

Create Pilot Production line

Fluxergy Logo

11

Create and test pilot production lots to evaluate production line (IQQQPQ)

Fluxergy Logo

12

Evaluate pilot lot performance per R&D performance

13

Run Verification and Validation

14

Run Clinical Trial

15

Commercialize

1

Develop Assay on 96 well plate

2

Develop hardware to replicate assay process

3

Test assay in R&D hardware configuration

4

Adjust hardware to make assay work

5

Complete R&D with working R&D assay and hardware configuration

6

Evaluate hardware and assay changes to allow for cost down/ supply chain

7

Test assay and hardware changes

8

Evaluate hardware and assay changes for manufacturability (automation, IPQC's, etc.)

9

Test assay and hardware changes

10

Create Pilot Production line

11

Create and test pilot production lots to evaluate production line (IQQQPQ)

12

Evaluate pilot lot performance per R&D performance

13

Run Verification and Validation

14

Run Clinical Trial

15

Commercialize

Multimodal testing

Fluxergy multimodal testing platform

Overview

Fluxergy has developed a multi-modal diagnostic platform which enables the transfer of assays from the laboratory to the point of care setting.

This includes molecular testing (e.g., PCR), immunoassays, cytometry assays and chemistry assays all within a single instrument.

The automated, sample-to-answer workflows can be customized for specific sample and testing methods, and partners can easily develop assays on the system to rapidly bring to the point-of-care using Fluxergy's open platform concept combined with flexible software and hardware manufacturing. 

Molecular

Design, develop, and deliver Molecular assays on the Fluxergy Platform.

Develop a multiplex molecular nucleic acid detection panel on an open, cost-effective POC Platform.

Technology Capabilities:

  • Multiplex PCR, RT-PCR, isothermal  

Features:

  • 6 individually temperature-controlled PCR reactions  
  • Can house probe or intercalating dyes in 2 fluorescent channels
  • Add lyophilization-compatible reagents directly onto the cartridge
  • On card - Pre-cycling, mixing, and thermal lysis capabilities

Analysis Features:

  • Qualitative and quantitative: Look at PCR fluorescence data on a POC machine
  • Individual Cycle threshold (CT) readings and melt curve analysis

Where are we going

  • 12+ target multiplex panels

Immunochemistry (LFA)

Deliver POC Immunoassays to address mass screening applications

Capable of housing quantitative immunoassay technologies for detection of protein and chemical analytes.

Technology capabilities: Fluorescent and visual lateral flow immunoassays (LFA), liquid-based immunoassays

Features:

-         Multiplex, multi-sample type assays

-         Built to read standard lateral flow strips

-         Visual and fluorescent readout capabilities

-         Read peak intensities of various concentrations at multiple points in the strip

Where are we going?

-         Multiplex, multi-sample type assays

Fluxergy test card

Chemistry

Detect Small Molecules with a flexible sensor system.

Read visual dry chemistry assays on a flexible cartridge to enable common biomarker and small molecule detection.

Technology Capabilities: dry-chemistry, dipstick chemistry, microfluidic chemistry assays

Features:

  • Utilize colorimetric chemistry assays
  • Visual/Fluorescent readout capabilites
  • Electrochemical sensor capability

Where are we going:

  • Building a CMP and BMP using electrochemical biosensor technology

Cytometry

Counting cells to characterizing morphology

Technological capabilities: fluorescence and visual-based image cytometry

Features:

  • Design custom algorithms for unlimited counting applications
  • Adaptable to reading pathology slides
  • Capture fluorescently died artifacts and morphological structures

Example Application: Fluxergy's white blood cell count cartridge

Multimodal testing

Fluxergy multimodal testing platform

Overview

Fluxergy has developed a multi-modal diagnostic platform which enables the transfer of assays from the laboratory to the point of care setting.

This includes molecular testing (e.g., PCR), immunoassays, cytometry assays and chemistry assays all within a single instrument.

The automated, sample-to-answer workflows can be customized for specific sample and testing methods, and partners can easily develop assays on the system to rapidly bring to the point-of-care using Fluxergy's open platform concept combined with flexible software and hardware manufacturing. 

Molecular

Design, develop, and deliver Molecular assays on the Fluxergy Platform.

Develop a multiplex molecular nucleic acid detection panel on an open, cost-effective POC Platform.

Technology Capabilities:

  • Multiplex PCR, RT-PCR, isothermal  

Features:

  • 6 individually temperature-controlled PCR reactions  
  • Can house probe or intercalating dyes in 2 fluorescent channels
  • Add lyophilization-compatible reagents directly onto the cartridge
  • On card - Pre-cycling, mixing, and thermal lysis capabilities

Analysis Features:

  • Qualitative and quantitative: Look at PCR fluorescence data on a POC machine
  • Individual Cycle threshold (CT) readings and melt curve analysis

Where are we going

  • 12+ target multiplex panels

Immunochemistry (LFA)

Deliver POC Immunoassays to address mass screening applications

Capable of housing quantitative immunoassay technologies fordetection of protein and chemical analytes.

Technology capabilities: Fluorescent and visuallateral flow immunoassays (LFA), liquid-based immunoassays

Features:

-         Multiplex, multi-sample type assays

-         Built to read standard Lateral flow strips

-         Visual and fluorescent readout capabilities

-         Read peak intensities of various concentrations at multiple points in the strip

Where are we going?

-         Multiplex, multi-sample type assays

Fluxergy test card

Chemistry

Detect Small Molecules with a flexible sensor system.

Read visual dry chemistry assays on a flexible cartridge to enable common biomarker and small molecule detection.

Technology Capabilities: dry-chemistry, dipstick chemistry, microfluidic chemistry assays

Features:

  • Utilize colorimetric chemistry assays
  • Visual/Fluorescent readout capabilites
  • Electrochemical sensor capability

Where are we going:

  • Building a CMP and BMP using electrochemical biosensor technology

cytometry data

Cytometry

Counting cells to characterizing morphology

Technological capabilities: fluorescence and visual-based image cytometry

Features:

  • Design custom algorithms for unlimited counting applications
  • Adaptable to reading pathology slides
  • Capture fluorescently died artifacts and morphological structures

Example Application: Fluxergy's white blood cell count cartridge

Featured assays

A simple and cost-effective method to detect the SeM/eqbE gene from an equine sample. *See Assay page for more information.
Rapid, clinically-relevant results for your patients and community. CE-IVD approved for point-of-care PCR.
Rapid, clinically-relevant results for your patients and community. CE-IVD approved for point-of-care PCR.
A simple, cost-effective test to ensure the veterinary hospital environment is protected from Salmonella.

Resource Center

Explore Fluxergy's information hub with webinars, product materials, how-to-videos, and more.

Learning Center

Download spec sheets, instructions, troubleshooting guides, and more.

"Fluxergy's technology has a great potential to start a new era in the diagnostic field. Fluxergy's portable, user-friendly, and cost-effective PCR technology provides highly accurate results in less than an hour, which is needed to control the spread of infectious diseases."

Dr. Lucjan Witkowski

Warsaw University of Life Sciences

“I love the Fluxergy Platform – I really do. You take your swab, mix it with the Fluxergy Reaction Mix, you load that in the test card, you stick it in the analyzer, and you wait an hour and the test is done. It’s really simple.”

Caroline Ignacio UCSD

UCSD Department of Medicine, CFAR Translational Virology Core​

“Two things about the Fluxergy system stand out, especially in the case of a viral pandemic: its accuracy using RT-PCR technology and its ability to deliver results in 1 hour at the point-of-care.”

Dr. David Smith UCSD

UCSD

"The Fluxergy platform’s speed, with results in one hour, and accuracy by using qPCR molecular technology are potentially strong benefits for clincal settings, especially when a quick result is needed. I also see the future value of the multimodal technology where you could potentially have different types of tests on a single point-of-care platform."

Lee B. Springer C3

C3 Clincal Consulting Services

“I learned of Fluxergy’s technology when I was at Boehringer Ingelheim, and I was impressed about the opportunity for this point-of-care testing platform. I am happy to be involved on Fluxergy’s advisory board where I can bring my 20+ years of animal health and R&D experience. One of the big advantages of Fluxergy’s technology is that it is very easy to use. When veterinarians see horses with high fevers, its important that they can understand quickly what is going on.”

Dr. Randolph Seidler

Boehringer Ingelheim

"Our collaboration with Fluxergy began with our interest in integrating one of our lab tests on their point-of-care cycler, the Fluxergy Analyzer. We worked closely with Fluxergy expert team to make adjustments to the cycling conditions and fluorescence signal, which led to optimization of the sensitivity and result calling within just a few weeks. The Fluxergy team was professional, knowledgeable, and always available to assist with any questions or concerns that we had. We are truly grateful for their hard work and dedication."

Dr. Damian Hertig

Ender

"We were looking to test our SOLISFast DNA Polymerase PCR Master Mixes on a point-of-care system. Fluxergy's platform was an excellent choice for this test, as the Fluxergy Analyzer is compatible with different cycling protocols, allowing for expanded testing capabilities. The collaboration proved to be successful, as we were able to validate the efficacy of our reagents while Fluxergy was able to successfully import an OEM partner's testing assay to the Fluxergy Works platform.

Reet Link PHD

Solis Biodyne

ISO 13485:2016
MDSAP
cGMP
CE IVD